The Potential Role of Doxycycline in the Treatment of Osteoarthritis of the Temporomandibular Joint

Abstract

Collagenase and gelatinase are matrix metalloproteinases (MMPs) which play an important role in tissue destruction in arthritic joints. Studies have demonstrated that tetracyclines can inhibit MMPs and prevent tissue destruction independent of their antimicrobial activity. The purpose of this pilot study is to assess the potential therapeutic role of Doxycycline in patients with advanced osteoarthritis of the temporomandibular joint (TMJ).

This ongoing investigation includes patients with a diagnosis of osteoarthritis of the TMJ based on clinical and diagnostic imaging findings, symptoms (localized TMJ pain, limited mobility, dysfunction) for a minimum of 36 months, and failure of previous non-surgical and surgical modalities to alleviate the symptoms. A synovial fluid sample is collected by a saline injection and aspiration technique, followed by diagnostic arthroscopy. Patients are placed on Doxycycline 50 mg BID for three months and then undergo repeat diagnostic arthroscopy and synovial fluid collection. The samples are stored at -80°C. Collagenase activity is determined by a combination of SDS-polyacrylamide gel electrophoresis and fluorography and calculated based on the percentage of collagen alpha chains that are degraded into alphaA breakdown products.

Three patients have completed the three-month course of Doxycycline thus far, and 5 joints with osteoarthritis have been analyzed. All patients were female (mean age = 35, mean duration of symptoms = 132 months) and had undergone previous bilateral arthroscopies. One patient had undergone unilateral arthroplasty. The mean collagenase activity showed 55% collagen lysis prior to Doxycycline treatment and 19% after three months of therapy. The mean

gelatinase activity was 28% prior to Doxycycline treatment and 7% after three months of therapy. The mean interincisal opening was 33 mm initially and 41 mm after three months of Doxycycline. Subjectively, two of the three patients reported significant improvement in their overall symptoms, which they had not experienced over the previous three years. One patient did not experience any change in symptoms, in spite of a marked reduction in collagenase activity from 86.4% to 9.6%.

Because of the very small numbers of patients enrolled in this pilot study so far, no statistically significant differences could be appreciated. However, the dramatic reduction in collagenase activity in these patients, with a long history of TMJ symptoms from osteoarthritis, suggests the potential promising role of Doxycycline in the management of osteoarthritis, and further investigation is warranted.

Keywords

Temporomandibular joint osteoarthritis doxycycline.

Get full access to this article

View all access options for this article.

References

Correlation between arthroscopic diagnosis of osteoarthritis and synovitis of the human temporomandibular joint and keratan sulfate levels in the synovial fluid. J Oral Maxillofac Surg 55:210-217.

Lohmander LS (1994). Articular cartilage and osteoarthritis. The role of molecular markers to monitor breakdown, repair and disease. J Anat 184:477-492.

Lohmander LS , Hoermer LA , Lark MW ( 1993). Metallo-proteinases, tissue-inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthrit Rheum 36:181-189.

Lohmander LS , Roos H. , Dahlberg L. , Hoermer LA , Lark MW ( 1994). Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint after injury to the cruciate ligament or meniscus. J Orthop Res 12:21-28.

Milam SB Schmitz JP (1995). Molecular biology of temporomandibular joint disorders-proposed mechanisms of disease. J Oral Maxillofac Surg 53:1448-1454.

Moskowitz RW , Goldberg VM (1988). Osteoarthritis. In: Primer on rheumatic diseases. Schumacher R , editor. Atlanta: Arthritis Foundation, pp. 170-176.

Mow VC , Ratcliffe A. , Poole AR (1992). Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13:67-97.

Murakami K. , Ito K. (1986). Arthroscopy of the temporomandibular joint. In: Arthroscopy of small joints. Watanabe M , editor. Tokyo: Igaku Shoin , pp. 128-139.

Myers SL , Flusser D. , Brandt KD , Heck DA ( 1992). Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis . J Rheumatol 19:1247-1251.

10.

Quinn JH Bazan MD (1990). Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints . J Oral Maxillofac Surg 48:968-971.

11.

Ramamurthy N. , Greenwald R. , Moak S. , Sciubba J. , Goren A. , Turner G. et al. (1994). CMT/Tenidap treatment inhibits temporomandibular joint destruction in adjuvant arthritic rats. Ann NY Acad Sci 732:427-430.

12.

Ratcliffe A. , Israel HA (1995). Proteoglycan components of articular cartilage in synovial fluids as potential markers of osteoarthritis of the temporomandibular joint. In: Temporomandibular disorders and related pain conditions, progress in pain research and management. Vol. 4. Sessle BJ , Bryant PS , Dionne RA , editors. Seattle, WA: IASP Press, pp. 141-150.

13.

Ratcliffe A. , Doherty M. , Maini RN , Hardingham TE (1988). Increased levels of proteoglycan components in the synovial fluids of patients with acute Joint disease. Ann Rheum Dis 47:826-832.

14.

Ratcliffe A. , Grelsamer RP , Kiernan H. , Saed-Nejad F. , Visco D. (1995). High levels of aggregan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis . Acta Scand Orthop 66:111-115.

15.

Revell PA , Mayston V. , Lalor P. , Mapp P. ( 1988). The synovial membrane in osteoarthritis: a histological study including the characterization of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 47:300-307.

16.

Saxne R. , Heinegard D. , Wollheim RA (1986). Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 45:491-497.

17.

Shafer DM , Assael L. , White LB , Rossomondo EF (1994). Tumor necrosis factor alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements . J Oral Maxillofac Surg 52:786-791.

18.

Stegenga B. , DeBont Lgm , Boering G. (1989). Osteoarthrosis as the cause of craniomandibular pain and dysfunction: a unifying concept. J Oral Maxillofac Surg 47:249-256.

19.

Stegenga B. , DeBont Lgm , Boering G. , Van Willigen JD (1991). Tissue responses to degenerative changes in the temporomandibularjoint: a review. J Oral Maxillofac Surg 49:1079-1088.